Literature DB >> 18423288

Quality of life evaluation of maxillomandibular advancement surgery for treatment of obstructive sleep apnea.

Kok Weng Lye1, Peter D Waite, Dan Meara, Deli Wang.   

Abstract

PURPOSE: The purpose of this study was to investigate the quality of life (QOL) for patients who underwent maxillomandibular advancement (MMA) surgery for obstructive sleep apnea (OSA) treatment using the Functional Outcomes of Sleep Questionnaire (FOSQ). Correlation of the findings with parameters from the polysomnograph (PSG) and physical examination were also performed. No QOL studies have been carried out for MMA in OSA, and the FOSQ is the most appropriate method. PATIENTS AND METHODS: The FOSQ instrument is a survey designed to evaluate QOL in OSA and proven to be effective. All patients followed a standard prospective protocol of pre- and 6 months postoperative data collection. Clinical radiographs, PSG, FOSQ, endoscopy, and computed tomography scans were analyzed.
RESULTS: Fifteen patients with complete data were included in the study. There was minimal change in the BMI from a preoperation mean of 32.10 to 31.50 at 6 months postoperation. The operation was 86.7% (13 of 15) successful (postoperative apnea and hypopnea index [AHI] decreased by 50% and was <20), with a significant decrease of the mean preoperation apnea-hypopnea index (AHI) of 69.12 to 13.87 postoperation (P < .0001). The minimum oxygen saturation (Lsat) correspondingly increased from a mean of 76.49 to 84.96 (P = .0001). A total of 93.3% of our patients achieved a successful QOL change based on a FOSQ score of greater than or equal to 18. There was statistically significant changes in all domains; general productivity (P = .0003), social outcome (P = .0020), activity level (P = .0008), vigilance (P = .0028), intimacy and sex (P = .0039), and the total score (P = .0002) postoperatively. Changes of Lsat and AHI were highly correlated (r = -0.728, P = .002). The magnitude of the Le Fort advancement was also found to be negatively correlated to the change in AHI (r = -0.544, P =.036). There was no correlation between the FOSQ scores and all other parameters, including both the PSG parameters (AHI and Lsat).
CONCLUSION: MMA remains the most effective operation for the treatment of OSA and yet no QOL studies have been carried out. The disease-specific QOL instrument (FOSQ) showed the subjective functional improvement in MMA patients. QOL instruments should be used for all surgical based treatment as they add a new dimension to the assessment of the patient and procedures.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18423288     DOI: 10.1016/j.joms.2007.11.031

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  18 in total

1.  Sleep physiology, abnormal States, and therapeutic interventions.

Authors:  Alvah T Wickboldt; Alex F Bowen; Aaron J Kaye; Adam M Kaye; Franklin Rivera Bueno; Alan D Kaye
Journal:  Ochsner J       Date:  2012

2.  Reply to the comment on: "Efficiency of bimaxillary advancement surgery in increasing the volume of the upper airways: a systematic review of observational studies and meta-analysis".

Authors:  Henrique Damian Rosário; Gustavo Mussi Stefan Oliveira; Irlan Almeida Freires; Felipe de Souza Matos; Luiz Renato Paranhos
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-06       Impact factor: 2.503

3.  Efficacy and safety of maxillomandibular advancement in treatment of obstructive sleep apnoea syndrome.

Authors:  M Giarda; M Brucoli; F Arcuri; R Benech; A Braghiroli; A Benech
Journal:  Acta Otorhinolaryngol Ital       Date:  2013-02       Impact factor: 2.124

4.  Changes in obstructive sleep apnea severity, biomarkers, and quality of life after multilevel surgery.

Authors:  Eric J Kezirian; Atul Malhotra; Andrew N Goldberg; David P White
Journal:  Laryngoscope       Date:  2010-07       Impact factor: 3.325

5.  Functional outcomes of sleep in Thai patients with obstructive sleep-disordered breathing.

Authors:  Wish Banhiran; Paraya Assanasen; Choakchai Metheetrairut; Cherdchai Nopmaneejumruslers; Wattanachai Chotinaiwattarakul; Jeerapa Kerdnoppakhun
Journal:  Sleep Breath       Date:  2011-08-17       Impact factor: 2.816

6.  Long-Term Effectiveness and Safety of Maxillomandibular Advancement for Treatment of Obstructive Sleep Apnea.

Authors:  Scott B Boyd; Arthur S Walters; Peter Waite; Susan M Harding; Yanna Song
Journal:  J Clin Sleep Med       Date:  2015-07-15       Impact factor: 4.062

Review 7.  Maxillomandibular advancement in obstructive sleep apnea syndrome patients: a restrospective study on the sagittal cephalometric variables.

Authors:  Paolo Ronchi; Valentina Cinquini; Alessandro Ambrosoli; Alberto Caprioglio
Journal:  J Oral Maxillofac Res       Date:  2013-07-01

8.  Treatment options for obstructive sleep apnea.

Authors:  Vivien C Abad; Christian Guilleminault
Journal:  Curr Treat Options Neurol       Date:  2009-09       Impact factor: 3.598

9.  Contemporary surgery for obstructive sleep apnea syndrome.

Authors:  Nelson B Powell
Journal:  Clin Exp Otorhinolaryngol       Date:  2009-09-23       Impact factor: 3.372

10.  Referral of adults with obstructive sleep apnea for surgical consultation: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment.

Authors:  David Kent; Jeffrey Stanley; R Nisha Aurora; Corinna G Levine; Daniel J Gottlieb; Matthew D Spann; Carlos A Torre; Katherine Green; Christopher G Harrod
Journal:  J Clin Sleep Med       Date:  2021-12-01       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.